AKR1B10


Summary: This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrenal gland, small intestine, and colon, and may play an important role in liver carcinogenesis. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in AKR1B10


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP TAS GO:0001523 retinoid metabolic process
BP IDA GO:0016488 farnesol catabolic process
BP IMP GO:0044597 daunorubicin metabolic process
BP IMP GO:0044598 doxorubicin metabolic process
BP IEA GO:0055114 oxidation-reduction process
CC IEA GO:0005576 extracellular region
Showing 1 to 6 of 18 rows rows per page

Gene expression in normal tissue: AKR1B10

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in AKR1B10


Loading, please wait...
Database
Pathway ID
Pathway Des.
wikipathways WP702 Metapathway biotransformation Phase I and II
kegg hsa00040 Pentose and glucuronate interconversions - Homo sapiens (human)
kegg hsa00051 Fructose and mannose metabolism - Homo sapiens (human)
kegg hsa00052 Galactose metabolism - Homo sapiens (human)
kegg hsa00561 Glycerolipid metabolism - Homo sapiens (human)
kegg hsa00790 Folate biosynthesis - Homo sapiens (human)
Showing 1 to 6 of 19 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD68 Paclitaxel 3
iGMDRD309 17AAG 1
Showing 1 to 2 of 2 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in AKR1B10

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​